Skip to main content Skip to footer

Driving digital in biopharma: Podcast

Tech-driven operations: Patients, antibodies & Daisy the AI Tool

Contributors:

Tom Lehmann

Managing Director – Life Sciences, Global R&D Lead

Áine Hanly

Chief Technology Officer – Vir Biotechnology

Inflection point: Transforming today’s labs for the future

Contributors:

Tom Lehmann

Managing Director – Life Sciences, Global R&D Lead

Richard Milne

Vice-president and General Manager of Digital Science Solutions – Thermo Fisher Scientific

Unlocking growth: Digital innovation in commercial manufacturing

Contributors:

Tom Lehmann

Managing Director – Life Sciences, Global R&D Lead

Morrey Atkinson

Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations, Vertex Pharmaceuticals

Driving digital in biopharma podcasts

Innovating oncology patient experience with data, digital & tech

Tom Lehmann talks with Samer Ansari, Head of Data, Digital, and Technology at Takeda Oncology to discuss the role of digital in creating exceptional HCP and patient experiences.

Harmonizing digital, data and traditional ways of working

Tom Lehmann talks with Chris Braithwaite, Novartis about the delicate balance required between traditional methods, rapidly emerging technology, and human decision-making to achieve digital transformation in biopharma.

Enabling tomorrow’s science through digital

Tom Lehmann talks with Micheal Rider, GSK about modernizing digital, data, and analytics capabilities across Development to  focus on near-term wins while planning for the future.

Rethink it: Digital is not a thing, digital is a means

Tom Lehmann  discusses the important of a strong digital core when evolving operation in biopharma with Jason Bronfeld, Head of Product Development IT, BMS.

Enabling tomorrow’s science through digital

Tom Lehmann talks with Anders Persson, AstraZeneca, about the role of digital and data in the transformation of global drug development.

Decentralized methods and the future of clinical research

Host Tom Lehmann talks with Craig Lipset, a long-time advocate and inspiring innovator in the clinical research and medicine development community.

Digital is greater than technology

Tom Lehmann discusses digital strategy and transformation wins with Guido Radack, Vice President, Strategic Initiatives Leader at Bayer.

From documents to data - Regulatory's future?

Tom and guest Eddie Reilly, Sanofi discuss delivering new therapies to patients more efficiently and how that’s enabled by regulatory affairs.

In search of the digital thread

Host Tom Lehmann talks with John Kelleher, head of digital quality for Pfizer global supply. John shares insights on connecting learnings and impacts of a digital QA transformation pilot to a more holistic QC transformation initiative.

Raising the innovation bar in early research and development

Lars and Tom discuss the journey to accelerate research and early development through lab automation...

Enabling scientific curiosity through digital in drug recovery

Tom and guest Julie Huxley-Jones, GSK, discuss the mindset of scientific curiosity, innovation and collaboration and its role on the impact of digital in scientific discovery.

Data is the new currency for drug development

Venkat and Tom discuss the critical role of data, design and digital and creating value with patients.

Digital at the pace of science

Kailash and Tom discuss strategy, how digital is improving patient health, the pace of technology, and future vision.

A human health care philosophy and digital transformation

Stephen and Tom talk about how Eisai’s focus on human health care is shaping the company’s digital approach.

Decentralized clinical research

Craig and Tom discuss priorities for clinical trial access and decentralized research methods.

In search of the digital thread

John and Tom talk about learnings from a digital transformation pilot and improving process.

The 4 P’s of digital transformation

Debraj and Tom discuss the enabling role of 4 P’s in a successful digital transformation.

Digital’s positive role in patient health

Tina, Jennifer and Tom discuss the COVID-19 patient-care reset.

Digital is greater than technology

Guido and Tom discuss clinical innovation, technology investment, decentralized trials and COVID’s role.

Digital at the pace of science

Kailash and Tom discuss strategy, how digital is improving patient health, the pace of technology, and future vision.

Digitalization in Biopharma R&D

Join Tom and Katie Miinch for the discussion that ignited our series!

Meet the host